Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice of extra general meeting in Skogsaktiebolaget Eternali

The shareholders of Skogsaktiebolaget Eternali, reg. no. 559247-4976, (the "Company") are hereby invited to the extra general meeting to be held on Tuesday 15 March 2022. The extra general meeting will be carried out through advance voting (postal voting) pursuant to temporary legislation. Thus, it will not be possible to attend in person or through proxy at the extra general meeting.Information with respect to the coronavirus  The Company is mindful of the health and well-being of its shareholders and employees. It´s important for the Company to take a social responsibility and

Raisio plc: Managers´ transactions

Raisio plc Managers´ transactions 15 February 2022   MANAGERS’ TRANSACTIONS   Person subject to the notification requirement Name: Lotta Haavisto Position: Closely associated person (1):Person Discharging Managerial Responsibilities In Issuer Name: Erkki Haavisto Position: Member of the Board Issuer: Raisio Oyj LEI: 74370083282NHIP4QD02   Notification type: INITIAL NOTIFICATION Reference number: 10125/5/4 ____________________________________________   Transaction date: 2022-02-14 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type:

DexTech Medical AB Half-year report July 1 - December 31, 2021

Correction, in the English version that was sent out recently, the MAR label and contact details were not attached, but they are now attached in this message.Summary of the Second Quarter (2021-10-01 – 2021-12-31) · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss amounted to MSEK -1,1 (-1,6) · Earnings per share* SEK -0.08 (-0.10) * Before dilution. Earnings per share: Profit for the period divided by the average number of shares 14,920,478. For the comparison period, the average number of shares was 14,920,478. Amounts in brackets refer to the corresponding

Humana AB has resolved to repurchase own shares

Under the authorisation from the Annual General Meeting 2021, the Board of Humana AB has resolved to repurchase own shares.The purpose of the repurchases is to adjust the capital structure and thereby contribute to increased shareholder value. The company’s holding of own shares may ultimately be used as payment for or to finance acquisitions of companies and/or assets. The Group’s financial position is considered to be strong, even after the resolved repurchases of shares, and provides the possibility to continue to develop the business. Any repurchase will be made on Nasdaq Stockholm

Invitation to InDex Pharmaceuticals’ Capital Markets Day on March 14, 2022

February 15, 2022 – InDex Pharmaceuticals Holding AB (publ) invites investors, analysts and media to a Capital Markets Day on March 14, 2022. The Capital Markets Day will be held in Krügersalen at Kapitel 8, Tändstickspalatset, Västra Trädgårdsgatan 15 in Stockholm. The presentations will start at 15.00 CET with registration from 14.30 CET.The focus of the Capital Markets Day will be on the ongoing phase III study CONCLUDE with the drug candidate cobitolimod, cobitolimod's market potential and InDex’s long-term strategies for commercialisation of cobitolimod. Cobitolimod is under

Q-Free: Mandatory notification of trade

(Oslo 15 February 2022) Trond Christensen, CFO of Q-Free ASA, has today bought 33,000 shares in Q-Free ASA, at an average price of NOK 7.30 per share. The shares were acquired through T Christensen AS, a company controlled by Christensen. Following the transaction, Christensen controls 45,000 shares in Q-Free ASA. The notification form is included in the attachment. This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Acquisitions of own shares in Evolution AB (publ)

Evolution AB (publ) (“Evolution”) has, during the period 9 February 2022 – 11 February 2022, acquired a total of 370,000 own shares within the framework of the repurchase programme introduced by the board of directors to improve the capital structure of Evolution by reducing the capital, and thereby creating added shareholder value.The repurchase programme, which Evolution announced on 3 December 2021, is being implemented in accordance with the EU Market Abuse Regulation No 596/2014 (“MAR”) and Commission Delegated Regulation No 2016/1052 (“Safe Harbour Regulation”). During the period 9

Metsä Group is the Finnish Athletics Federation's main partner in children's and youth athletics

Metsä Group press release 15 February 2022Metsä Group and the Finnish Athletics Federation (SUL) have agreed on a main partnership for children’s and youth athletics in 2022-2024. At the heart of the co-operation are the Seurakisat for children and youth. Seurakisat are held annually in about 500 different locations in Finland. Approximately 30,000 young people are targeted to take part in the competition during the summertime. Participants are under the age of five to about fifteen. “The experiences and lessons learned in the field of sport carry you throughout your life. We want to

FlexQubes CEO comments on fourth quarter 2021: VIDEO

“Our most successful year to date, with new records in both sales and order intake for the quarter and for the full year.” Anders Fogelberg CEO of FlexQube and Heidi Bader CFO of FlexQube comment on the results of the fourth quarter 2021. Link to film for the fourth quarter 2021: https://vimeo.com/677642411 About FlexQube FlexQube is a technology company headquartered in Gothenburg, Sweden with subsidiaries in USA, Mexico, Germany and England. FlexQube offers solutions for cart-based material handling using a patented modular concept. FlexQube develops and designs customized

Stora Enso: Managers’ transactions

STORA ENSO OYJ MANAGERS’ TRANSACTIONS 15 February 2022 at 14.00 EETStora Enso Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Karin Nilsson Position: Closely associated person   (1): Person Discharging Managerial Responsibilities In Issuer Name: Richard Nilsson Position: Member of the Board   Issuer: Stora Enso Oyj LEI: 7437000ZP669LKUTZ738 Notification type: INITIAL NOTIFICATION Reference number: 10126/5/6 ____________________________________________   Transaction

Green Landscaping Group is increasing its presence in Skåne and Halland through the acquisition of Hallandsåsens Utemiljö

15 February 2022, 13:00 CET Green Landscaping Group AB (publ) has today acquired Hallandsåsens Utemiljö AB, a leading company in the management and fine planning of outdoor environments in northern Skåne and Halland.Hallandsåsens Utemiljö was founded in 2008 and is a family company that constructs and manages outdoor environments. The company also delivers plants. Today, sales amount to approximately SEK 30 million with good profitability and 18 employees. The company is based in Laholm, but the customers are located in northern Skåne and Halland. Oscar Åhslund, CEO, is the fourth

Länsförsäkringar Alliance: Annual Review in summary 2021

2021 in brief Figures in parentheses pertain to the full-year 2020. · Operating profit for the Länsförsäkringar Alliance’s non-life insurance operations increased to SEK 19,734 M (7,252), with investment income of SEK 19,306 M (6,950). Bonuses and discounts to customers amounted to SEK 2,571 M (1,832). · The technical result for the Länsförsäkringar Alliance’s non-life insurance operations increased to SEK 4,126 M (2,873). Premiums earned after ceded reinsurance rose 6% to SEK 31,193 M (29,397). The combined ratio amounted to 91.5% (92.9). · The Länsförsäkringar AB Group’s

MARK Display Standard Range Relieves Manufacturing Hands

ProGlove’s wearable barcode scanners are a major relief for manufacturers across industries. Yet MARK Display Standard Range, the latest extension , may very well become a real lifeline for shop floor operators. After all, it helps optimize overall efficiency, process reliability, and worker well-being. Here is how.So, what are some issues manufacturing organizations face? And maybe more importantly, how can MARK Display Standard Range 

BNP Paribas announces Head of Communications and Company Engagement in the Nordic region

BNP Paribas announces the appointment of Jennie Casselborg as Head of Strategic Marketing, Communications and Company Engagement in the Nordic region. Jennie will lead the Group’s communications and CSR activities in the Nordic region and will report to Eirik Winter, CEO for BNP Paribas Group Nordic Region.Jennie joins from Franklin Templeton where she most recently held a position as Head of Marketing & Communications in the Nordic region. In the last three years, BNP Paribas has doubled revenues with the region’s clients and hired almost 200 people in the Nordic region. Today the group

Company Announcement No. 19, 2022 – Addendum to Nordea Kredits final terms

The following security codes have been added to the final terms of fixed rate callable covered mortgage bonds (SDRO): Callable fixed-rate annuity bond ISIN code Nom Name        Opening Closing Maturity Currency interest date date date rate/ Maturity DK0002053545 2.0% 2.0NDASDRO43 17/02 31/08 01/10 DKK          2043 -2022 -2023 -2043     DK0002053461 2.5% 2.5NDASDRO53 17/02 31/08 01/10 DKK          2053

DexTech Medical AB, Half-year report July 1 - December 31, 2021

Summary of the Second Quarter (2021-10-01 – 2021-12-31) · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss amounted to MSEK -1,1 (-1,6) · Earnings per share* SEK -0.08 (-0.10) * Before dilution. Earnings per share: Profit for the period divided by the average number of shares 14,920,478. For the comparison period, the average number of shares was 14,920,478. Amounts in brackets refer to the corresponding period last year. Summary of the First Half-year (2021-07-01 – 2021-12-31) · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss amounted to

Presentation of K-Fastigheter’s Year-end report 2021

K-Fast Holding AB (“K-Fastigheter”) publishes its Year-end report 2021 on 17 February 2022, before the opening of the stock market. The report will be presented in a pre-recorded audio cast at 10.00 a.m. CET the same day.Jacob Karlsson, CEO, and Martin Larsson, CFO, will present the earnings and operations. The presentation materials (slides + sound) will be available at www.k-fastigheter.com/en/investors/presentations. The presentation will be held in Swedish, with presentation materials in English.Questions may be addressed in writing to ir@k-fastigheter.se with answers being

Human olfactory mucosa cell model opens a new perspective on Alzheimer’s disease

Researchers at the University of Eastern Finland have developed and characterized a new cell model for Alzheimer’s disease that has wide utility for research and could prove useful in early diagnosis and testing of new therapies. In collaboration with clinicians at Kuopio University Hospital, the researchers collected nasal biopsies from cognitively healthy individuals and patients diagnosed with Alzheimer’s disease over several years. Following tissue processing, the researchers applied a powerful single cell RNA sequencing approach to characterize the patient-derived cells of the

Global UTM Association Kicks Off 2022 with New Strategic Direction

Brussels, 15 February 2022 - Amid new developments in technology, standards and global regulations has led the Global Uncrewed Traffic Management Association (GUTMA) to take a step forward and start 2022 by infusing the Association with a new strategic direction and mission statement. The Association comes up with a clear vision for the next five years, alongside creating new working groups and high-level assets for the industry. The Association will also hold an online conference on a competitive U-space services market on 15[th] March 2022.Bolstered by 60 global drone companies membership,

Q-Free: Mandatory notification of trade

(Oslo 15 February 2022) Geir Bjørlo, member of the Board of Directors of Q-Free ASA, has today bought 34,947 shares in Q-Free ASA, at an average price of NOK 7.38 per share. The shares were acquired through Illuminator AS, a company controlled by Bjørlo. Following the transaction, Bjørlo controls 152,093 shares in Q-Free ASA. The notification form is included in the attachment. This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Asetek Announces Exclusive Supply Agreement with Motor Manufacturer HangZhou MiGE

Hangzhou MiGE Electric to Produce Asetek Sim Racing Wheel Bases Combining Its Premium Motor Technology and Asetek Design and ElectronicsAalborg, Denmark – February 15, 2022 –– Asetek, sim racing gear innovator, the creator of the all-in-one liquid cooler, and the global leader in liquid cooling solutions for gaming PCs and DIY enthusiasts, today announced an exclusive supply agreement with HangZhou MiGE Electric Co., Ltd. (MiGE) for its high-end wheel bases for sim racing. MiGE will use its highly-effective servo motor technology to produce a full range of wheel bases exclusively for Asetek

BEWI - Updated information regarding extraordinary general meeting to be held on 16 February 2022

Reference is made to the stock exchange notice by BEWI ASA on 26 January 2022 regarding the notice of the extraordinary general meeting (EGM) to be held on 16 February 2022 at 11:00 CET at the offices of Advokatfirmaet Thommessen AS (Ruseløkkveien 38, 0251 Oslo). Due to the ongoing situation relating to the spread of the Covid-19 virus (especially the Omicron variant), the shareholders have been encouraged to abstain from appearing in person at the EGM, but instead to participate by following the meeting through Microsoft Teams. BEWI will provide guidance on how to attend the EGM

Pfizer’s announced purchase of Arena Pharmaceuticals exemplifies a satisfactory acquisition within the CBD medical treatment industry

CS MEDICA A/S (”CS MEDICA” or the ”Company”) see a strategic turnaround and new era for the CBD Medical treatment sector as Pfizer has announced the acquisition of Arena Pharmaceuticals. The acquisition exemplifies Big Pharma moving into the Cannabinoid treatment space and acknowledging Cannabinoids (CBD) in the medical treatment market.Pfizer’s announced[1] purchase of the US clinical-trial stage cannabinoids company, Arena Pharmaceuticals, exemplifies a satisfactory acquisition and a game-changer for CS MEDICA and the CBD medical treatment industry in which the Company operates. With this

There are no items matching the current filter
There are no more items matching the current filter
Back to top